For the twentieth year, the Association of Universities Tech transfer Managers published, at the end of 2010, a report that contains many economic indicators related to the development of technology transfer (TT) in the country. These different indicators were established by a group of experts twenty years ago, with the goal of providing a clear vision of the reality of technology transfer landscape in the United States. This 2010 AUTM survey is gives the Office of Science & Technology of the French Consulate an opportunity to report quantitative data on the latest developments in technology transfer in the United States. In this first part, we will put an emphasis on the most significant data of TT in the United States, considered in its entirety. Continue reading
Annual report of the Association of Universities Tech Transfer Managers – Part 1 : analysis of 2010 main indicators
Reply
The part 1 paper addresses the issue of US manufacturing and innovation. After Obama’s Advance Manufacturing Program initiative last year the author notes that little impact in both the US manufacturing industry and the literature has been observed. The AMP looks presently outdated by the recent figure regarding the manufacturing world share : China is turning the leading country with 19,8% and has overtaken the U.S. with 19,4%. The article explores two ambivalent trends underlying the globalization in manufacturing : (1) the propensity of US firms to outsource manufacturing in China, making the business of US firms very profitable (cf. Apple) and the customer satisfaction higher, making the US trade deficit with China acceptable, and (2) the propensity to transfer innovation capability to China when manufacturing is located there, preventing the US manufacturing firms to do so. (to be continued)
The first spot is undoubtedly occupied by California, and 2011 statistics confirm the domination more than ever.
.jpg "Research and development")
In our new article, we explore one important aspect of the evolution of big pharmaceutical companies towards new models of development : the outsourcing of their R&D capacities, evolving towards a Search & Development model. Is it now widely recognized that the big pharmaceutical companies have completely remodeled their R&D system for drug development. 
Fait accompli! The National Center for Advancing Translational Sciences (NCATS) is launched by the NIH !The Obama administration will provide $30.7 billion to NIH for FY 2012 which includes $576.5 million to fund the NCATS. This article presents this new center that will focus on advancing translational research projects and moving basic research findings into applied innovations. A major step of the Obama Administration for innovation.
Jointly drawn up by David and Antoine, the paper explores the recent trends impacting US innovation activities in 2011. It also identifies the key questions facing the funding of innovation, including the VC activities in 2012 and the development of new funding schemes. A large section of the paper addresses the US Federal policy in the field of innovation, including the “Start up America” initiative. Although challenged by various negative factors, such as the poor economic outlook, the US innovation system appears both robust and flexible.
Summary 
